10,162 Results

Data from RADIANCE-HTN SOLO trial of Paradise Renal Denervation System for hypertension results

 Added 1 day ago

ReCor Medical announced the 6 month "on-medication" results from its RADIANCE-HTN SOLO clinical trial with simultaneous publication in Circulation, and...

MOMENTUM 3 study of HeartMate 3 LVAD meets primary endpoint in heart failure

 Added 1 day ago

Abbott announced new late-breaking data from the MOMENTUM 3 study, the world's largest randomized controlled trial to assess outcomes in...

Phase IV AUGUSTUS trial of Eliquis shows superiority in non-valvular atrial fibrillation

 Added 1 day ago

Bristol-Myers Squibb/Pfizer announced results from the Phase IV AUGUSTUS trial evaluating Eliquis (apixaban) versus vitamin K antagonists (VKAs) in patients...

FDA approves Trazimera biosimilar to Herceptin to treat breast and gastric cancers

 Added 1 day ago

The FDA has approved Trazimera (trastuzumab-qyyp), a biosimilar to Herceptin (trastuzumab), for the treatment of human epidermal growth factor receptor-2...

Early menopause in smokers linked to bladder cancer

 Added 4 days ago

Research shows that experiencing menopause before the age of 45 is associated with a higher risk of bladder cancer. 

PARTNER 3 Trial shows SAPIEN 3 valve superior to surgery in severe aortic stenosis

 Added 2 days ago

Edwards Lifesciences announced that the results of the randomized PARTNER 3 Trial demonstrated superiority for the SAPIEN 3 transcatheter aortic...

EC approves Praluent for CV risk in adults with CV disease

 Added 2 days ago

The European Commission (EC) has approved a new indication for Praluent (alirocumab), from Sanofi + Regeneron, to reduce cardiovascular (CV)...

FDA approves Dupixent to treat adolescents with atopic dermatitis

 Added ago

The FDA has approved Dupixent (dupilumab) for adolescent patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose...

Interim analysis of REPAIR study of Opsumit shows improved heart function in pulmonary arterial hypertension

 Added 3 days ago

Actelion Pharmaceuticals announced an interim analysis from the Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension (REPAIR) study of Opsumit (macitentan)...

EU approves MabThera for pemphigus vulgaris

 Added 3 days ago

Roche announced that the European Commission has approved MabThera (rituximab) for the treatment of adults with moderate to severe pemphigus...

Load more